Abstract
Most of the signal transduction pathways are mediated by protein kinases regulating every aspect of cell function. Mutations which deregulate their expression or their function or both result in cancers. Therefore, protein kinase inhibitors have become the focus of development of new therapies for cancer. A comprehensive review of Choline kinase (ChoK) was published by us in 2003. Since then, molecular information of ChoK inhibitors has been accumulated. In this review, we intend to summarize the new lines of evidence that will include the design of the most active antiproliferative agents so far described against ChoK. Studies have been aimed at the establishment of structure-activity relationships and the structural parameters that define ChoK inhibitory and antiproliferative activities of a set of twenty-five acyclic biscationic pyridophane and forty acyclic biscationic quinolinephane compounds. The corresponding QSAR equation was obtained for the whole set of bisquinolinium compounds for the antiproliferative activity, taking into consideration the electronic parameter σR of R4, the molar refractivity (MR) of R8, and the lipophilic parameters clog P and πlinker. The most potent antiproliferative agent shows an IC50 = 0.45 μM, predicted by the QSAR equation, whilst its experimental value is IC50 = 0.20 μM. Finally, toxicity assays were performed for the most promising compounds because of their interesting antiproliferative activities [IC50 HT-29 = 0.70, 0.80, 1.50 and 1.90 μM] and low toxicity [LD50 = 16.7, 12.5, > 25 and > 20 μg/kg of mouse]. These biological activities justify further analysis for antitumoral assays under in vivo conditions.
Keywords: Ab initio calculations, Antitumor drugs, Bispyridinium compounds, Bicyclophanes, Bisquinolinium compounds, Cyclophanes, Choline Kinase, QSAR
Current Medicinal Chemistry
Title: (Q)SAR Studies to Design New Human Choline Kinase Inhibitors as Antiproliferative Drugs
Volume: 13 Issue: 11
Author(s): J. M. Campos, R. M. Sanchez-Martin, A. Conejo-Garcia, A. Entrena, M. A. Gallo and A. Espinosa
Affiliation:
Keywords: Ab initio calculations, Antitumor drugs, Bispyridinium compounds, Bicyclophanes, Bisquinolinium compounds, Cyclophanes, Choline Kinase, QSAR
Abstract: Most of the signal transduction pathways are mediated by protein kinases regulating every aspect of cell function. Mutations which deregulate their expression or their function or both result in cancers. Therefore, protein kinase inhibitors have become the focus of development of new therapies for cancer. A comprehensive review of Choline kinase (ChoK) was published by us in 2003. Since then, molecular information of ChoK inhibitors has been accumulated. In this review, we intend to summarize the new lines of evidence that will include the design of the most active antiproliferative agents so far described against ChoK. Studies have been aimed at the establishment of structure-activity relationships and the structural parameters that define ChoK inhibitory and antiproliferative activities of a set of twenty-five acyclic biscationic pyridophane and forty acyclic biscationic quinolinephane compounds. The corresponding QSAR equation was obtained for the whole set of bisquinolinium compounds for the antiproliferative activity, taking into consideration the electronic parameter σR of R4, the molar refractivity (MR) of R8, and the lipophilic parameters clog P and πlinker. The most potent antiproliferative agent shows an IC50 = 0.45 μM, predicted by the QSAR equation, whilst its experimental value is IC50 = 0.20 μM. Finally, toxicity assays were performed for the most promising compounds because of their interesting antiproliferative activities [IC50 HT-29 = 0.70, 0.80, 1.50 and 1.90 μM] and low toxicity [LD50 = 16.7, 12.5, > 25 and > 20 μg/kg of mouse]. These biological activities justify further analysis for antitumoral assays under in vivo conditions.
Export Options
About this article
Cite this article as:
Campos M. J., Sanchez-Martin M. R., Conejo-Garcia A., Entrena A., Gallo A. M. and Espinosa A., (Q)SAR Studies to Design New Human Choline Kinase Inhibitors as Antiproliferative Drugs, Current Medicinal Chemistry 2006; 13 (11) . https://dx.doi.org/10.2174/092986706776872961
DOI https://dx.doi.org/10.2174/092986706776872961 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
QSAR and Molecular Modeling Studies on a Series of Indole-based Pyridone Analogues as HCV NS5B Polymerase Inhibitors
Letters in Drug Design & Discovery Antagonists of IAP Proteins: Novel Anti-Tumor Agents
Current Medicinal Chemistry Fragment-Based Discovery of Inhibitors of Protein Kinase B
Current Topics in Medicinal Chemistry Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review
Current Pharmaceutical Biotechnology Design, Synthesis and Biological Evaluation of 2, 4, 5-Triphenylimidazole Derivatives with Preliminary SAR
Letters in Drug Design & Discovery Designing of a Novel Candidate Multi-epitope Vaccine to boost Immune Responses against SARS‐COV‐2 using Immunoinformatics and Machine Learning based Approach
Letters in Drug Design & Discovery Prospects of Antiviral Drugs Derived from Natural Products: Targeting SARS-CoV Entry and Replication
Current Traditional Medicine Synthetic Pulmonary Surfactant Preparations: New Developments and Future Trends
Current Medicinal Chemistry Chemical Biology of mGlu4 Receptor Activation: Dogmas, Challenges, Strategies and Opportunities
Current Topics in Medicinal Chemistry Synthesis and Evaluation of the in vitro Antimicrobial Activity of Triazoles, Morpholines and Thiosemicarbazones
Medicinal Chemistry Synthesis and In-Vitro Antitumor Activity of Selected 7-Fluoro-6-(4-methyl-1-piperazinyl)-2-(thiosubstituted)-4(3H)-quinazolinones
Letters in Organic Chemistry Preface
Current Medicinal Chemistry - Central Nervous System Agents Lessons Learned from the Covid-19 Outbreak and its Impact: A Generalized Study
Current Signal Transduction Therapy Impact of Novel Screening Technologies on Ion Channel Drug Discovery
Combinatorial Chemistry & High Throughput Screening Managing Nutrition for Cancer Patients during COVID-19: Review
Current Nutrition & Food Science Overview of Covid-19 Regarding the Cardiovascular Situation in the Light of Current Reports
Cardiovascular & Hematological Disorders-Drug Targets QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors
Current Pharmaceutical Design Apolipoprotein-ε4 allele (APOE-ε4) as a Mediator of Cognitive Loss and Dementia in Long COVID-19
Current Neurovascular Research Discovery of 3,4-Diaminocyclobut-3-ene-1,2-dione-Based CXCR2 Receptor Antagonists for the Treatment of Inflammatory Disorders
Current Topics in Medicinal Chemistry Predicting Drugs and Proteins in Parasite Infections with Topological Indices of Complex Networks: Theoretical Backgrounds, Applications and Legal Issues
Current Pharmaceutical Design